Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

640 ARTÍCULOS , VIENDO DEL 61 AL 75

Early-onset Alzheimer Disease and Its Variants

Mendez MF.

Continuum (Minneap Minn). 2019 Feb;25(1):34-51. doi: 10.1212/CON.0000000000000687.

Primary Progressive Aphasias and Apraxia of Speech

Botha H, Josephs KA.

Continuum (Minneap Minn). 2019 Feb;25(1):101-127. doi: 10.1212/CON.0000000000000699.

Vascular Cognitive Impairment

Graff-Radford J.

Continuum (Minneap Minn). 2019 Feb;25(1):147-164. doi: 10.1212/CON.0000000000000684.

Depression and Antidepressants as Potential Risk Factors in Dementia: A Systematic Review and Meta-analysis of 18 Longitudinal Studies

Chan JYC, Yiu KKL, Kwok TCY, Wong SYS, Tsoi KKF.

J Am Med Dir Assoc. 2019 Mar;20(3):279-286.e1. doi: 10.1016/j.jamda.2018.12.004. Epub 2019 Jan 30.

Progression of logopenic aphasia to frontotemporal dementia in an amyloid β-negative and (18) F-THK-5351-positive patient

Takaya M, Ishii K, Kubota I, Shirakawa O.

Psychogeriatrics. 2019 Jul;19(4):399-401. doi: 10.1111/psyg.12396. Epub 2019 Feb 3.

Drug interactions with dementia-related pathophysiological pathways worsen or prevent dementia

Barus R, Béné J, Deguil J, Gautier S, Bordet R.

Br J Pharmacol. 2019 Sep;176(18):3413-3434. doi: 10.1111/bph.14607. Epub 2019 Mar 31.

Imaging in prodromal dementia with Lewy bodies: Where do we stand?

Durcan R, Donaghy P, Osborne C, Taylor JP, Thomas AJ.

Int J Geriatr Psychiatry. 2019 May;34(5):635-646. doi: 10.1002/gps.5071. Epub 2019 Mar 15.

Potentially modifiable factors associated with agitation and aggression in Alzheimer's disease: results of the ICTUS study

de Mauleon A, Soto M, Ousset PJ, Nourhashemi F, Lepage B, Vellas B.

Int Psychogeriatr. 2019 Oct;31(10):1509-1516. doi: 10.1017/S1041610218001990.

Differences in Cognitive Impairment in Primary Age-Related Tauopathy Versus Alzheimer Disease

Besser LM, Mock C, Teylan MA, Hassenstab J, Kukull WA, Crary JF.

J Neuropathol Exp Neurol. 2019 Mar 1;78(3):219-228. doi: 10.1093/jnen/nly132.

The comparison of cognitive function and risk of dementia in CKD patients under peritoneal dialysis and hemodialysis: A PRISMA-compliant systematic review and meta-analysis

Tian X, Guo X, Xia X, Yu H, Li X, Jiang A.

Medicine (Baltimore). 2019 Feb;98(6):e14390. doi: 10.1097/MD.0000000000014390.

Validation of the revised classification of cognitive and behavioural impairment in ALS

Iazzolino B, Pain D, Peotta L, Calvo A, Moglia C, Canosa A, Manera U, Ilardi A, Bombaci A, Zucchetti JP, Mora G, Chio A.

J Neurol Neurosurg Psychiatry. 2019 Jul;90(7):734-739. doi: 10.1136/jnnp-2018-319696. Epub 2019 Feb 7.

Dementia in Down syndrome: unique insights for Alzheimer disease research

Lott IT, Head E.

Nat Rev Neurol. 2019 Mar;15(3):135-147. doi: 10.1038/s41582-018-0132-6.

The role of repetitive transcranial magnetic stimulation (rTMS) in the treatment of cognitive impairment in patients with Alzheimer's disease: A systematic review and meta-analysis

Lin Y, Jiang WJ, Shan PY, Lu M, Wang T, Li RH, Zhang N, Ma L.

J Neurol Sci. 2019 Mar 15;398:184-191. doi: 10.1016/j.jns.2019.01.038. Epub 2019 Jan 24.

PPAR-δ and erucic acid in multiple sclerosis and Alzheimer's Disease. Likely benefits in terms of immunity and metabolism

Altinoz MA, Ozpinar A.

Int Immunopharmacol. 2019 Apr;69:245-256. doi: 10.1016/j.intimp.2019.01.057. Epub 2019 Feb 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias